????????
The global Oligonucleotide Synthesis Market is experiencing significant growth, driven by the increasing demand for personalized medicine, advancements in biotechnology, and rising investments in pharmaceutical research and development. Oligonucleotides, short sequences of nucleic acids, are essential in various applications, including diagnostics, therapeutics, and research. The market was valued at USD 6.60 billion in 2023 and is projected to reach USD 17.43 billion by 2030, growing at a CAGR of 14.87% during the forecast period
This growth is attributed to the expanding use of synthesized oligos in therapeutic and diagnostic applications, ongoing developments in technologies such as next-generation sequencing (NGS) and CRISPR, and increasing investments by governments and major players in life science research and synthetic biology
Estimated Growth Rate for Oligonucleotide Synthesis Market
Oligonucleotide Synthesis Market was valued at US$ 6.60 Bn in 2023 and is expected to reach 17.43 Bn by 2030, at a CAGR of 14.87% during the forecast period.
Ask for Sample to Know US Tariff Impacts on Market @https://www.maximizemarketresearch.com/request-sample/31248/
Regional Analysis :
North America:
North America is expected to hold the largest market size for oligonucleotide synthesis globally, driven by robust pharmaceutical R&D activities, advanced healthcare infrastructure, and significant investments in biotechnology. The United States, in particular, is home to numerous biotech hubs and research clusters, fostering collaborations between academia, industry, and government bodies
Asia Pacific:
The Asia-Pacific region is anticipated to experience the highest CAGR, mainly owing to the rising accessibility of synthesized oligos, along with a rise in R&D funding and activities in the region. Japan and China are considered the most attractive markets with respect to growth opportunities, while India is emerging as a fast-growing market due to increasing healthcare expenditures, growing biotech industry, and rising prevalence of chronic diseases
Oligonucleotide Synthesis Market Segmentation:
by Product Type
Reagents & Consumables
Equipment
Synthesized oligonucleotides
DNA oligonucleotides
RNA oligonucleotides
Others
by End User
Hospital
Pharmaceutical & Biotechnology Companies
Diagnostic Laboratories
CROs & CMOs
Academic Research Institutes
The market for oligonucleotide synthesis is anticipated to be led by the biotechnology & pharmaceutical companies segment. Businesses in the biotechnology and pharmaceutical sectors are concentrating on finding new ways to treat illnesses. Because oligonucleotides provide an efficient mechanism of action for the treatment of multiple indications at relatively lower development costs, these businesses are consequently using them extensively.
by Application
Research
Polymerase Chain Reaction (PCR)
Next Generation Sequencing
Therapeutics
Antisense Oligonucleotides
Nucleic Acid Aptamers
Diagnostics
Others
Request a Sample of the US Tariff Impact Analysis Report:https://www.maximizemarketresearch.com/request-sample/31248/
Key Players :
Discover strategies of the key players in the market and explore how they are navigating trends, expanding their portfolios, and capitalizing on emerging applications. From global leaders to regional influencers, this report provides a complete competitive analysis.
1. Gilent Technologies
2. Adtbio
3. Bioautomation
4. Bio-Synthesis Inc.
5. Eurofins Genomics
6. Eurogentec
7. GE Healthcare
8. Genscript
9. Genedesign
10. Integrated DNA Technologies
11. LGC Biosearch Technologies
12. Merck KGaA
13. Nitto Denko Avecia
14. Thermo Fisher Scientific
15. Trilink Biotechnologies
16. Agilent Technologies, Inc.
17. Adtbio
18. Sarepta Therapeutics, Inc. (US).
19. Danaher Corporation
20. GeneDesign, Inc.
21. Kaneka Corporation (Japan)
22. Maravai Lifesciences Holdings, Inc. (US)
23. Azenta, Inc. (US)
24. Twist Bioscience Corporation (US)
For deeper market insights, peruse the summary of the research report:https://www.maximizemarketresearch.com/market-report/global-oligonucleotide-synthesis-market/31248/
Key Highlights:
- Historical Market Data (2018-2023)
- Forecasts by Segment, Region, and Industry Application (2024-2030)
- SWOT Analysis, Value Chain Insights, and Growth Drivers
- Legal Aspects by Region and Emerging Opportunities
Top Questions Answered:
- What are the key growth drivers and trends in the market?
- Who are the major players, and how do they maintain a competitive edge?
- What new applications are poised to revolutionize the Oligonucleotide Synthesis industry?
- How will the market grow in the coming years, and at what rate?
Latest cutting-edge research from Maximize Market Research is now trending:
♦ global aluminium oxide market
♦ Global Medical Elastomers Market
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 9607195908, +91 9607365656
